InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,105.56
(
1.13%
)
US TECH 100
17,245.20
(
1.57%
)
Dow Jones
38,277.65
(
0.50%
)
Brent Oil
88.27
(
0.13%
)
Bitcoin
63,611.95
(
-1.35%
)
Post# of 596791
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Robertscott

Send PM Follow Ignore
Followers 97
Posts 128742
Boards Moderated 1
Alias Born 07/24/2016

Robertscott

Member Level

Re: None

Thursday, 12/08/2016 8:50:16 AM

Thursday, December 08, 2016 8:50:16 AM

Post# of 596791
$ENTB Regen BioPharma Inc. (OTCQB: RGBPP) In a recent study published in the International Journal of Molecular Sciences a team of scientists in Guangzhou, China[1] have demonstrated that expression of NR2F6 in patients with early cervical cancer correlates with poor prognoses. These scientists tested for NR2F6 in patient's cervical cancer tissue as well as in the normal tissue surrounding each of their tumors.

http://www.otcmarkets.com/stock/ENTB/news
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up